Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News PepGen Inc PEPG

Healthcare Biotechnology
PepGen Inc. is a clinical-stage biotechnology company. The Company is engaged in advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. Its proprietary enhanced delivery oligonucleotide (EDO), platform leverages cell-penetrating peptides to improve the uptake and activity of conjugated... see more

Recent & Breaking News (NDAQ:PEPG)

An Inquiry Has Been Launched Into Whether PepGen Inc Violated Securities Laws And Investors Are Invited To Assist

Accesswire September 1, 2024

The Schall Law Firm Encourages The Public To Partake In The Firm's Securities Fraud Investigation Into PepGen Inc.

Accesswire August 31, 2024

Investors Are Invited By The Schall Law Firm To Contribute To An Inquiry Into PepGen Inc's Possible Securities Law Violations

Accesswire August 30, 2024

The Schall Law Firm Is Looking Into Whether PepGen Inc. Violated Securities Regulations And Stockholders Are Urged To Take Part

Accesswire August 29, 2024

An Investigation Has Been Launched Into PepGen Inc For Securities Fraud And Investors Are Invited By The Schall Law Firm To Assist

Accesswire August 28, 2024

Shareholders Should Contact The Schall Law Firm About An Inquiry Into PepGen Inc For Potentially Violating Securities Regulations

Accesswire August 27, 2024

The Schall Law Firm Is Looking Into PepGen Inc For Possible Securities Fraud And Investors Are Invited To Assist

Accesswire August 26, 2024

PepGen Inc Is Being Investigated For Securities Law Infractions And The Schall Law Firm Is Looking For Shareholders To Participate

Accesswire August 25, 2024

A Securities Fraud Inquiry Has Been Opened Into PepGen Inc And The Schall Law Firm Is Seeking Investors With Losses To Reach Out

Accesswire August 24, 2024

The Schall Law Firm Is Investigating PepGen Inc For Potential Violations Of Securities Laws And Affected Stockholders Are Encouraged To Join

Accesswire August 23, 2024

The Schall Law Firm Is Investigating PepGen Inc For Possible Securities Law Violations And Encourages Shareholders To Join

Accesswire August 22, 2024

Investors With Losses In PepGen Inc Are Invited To Participate In A Securities Fraud Investigation With The Schall Law Firm

Accesswire August 21, 2024

PepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Executive Vice President, Research & Development

Business Wire August 20, 2024

Shareholders Urged To Join The Schall Law Firm In A Securities Fraud Investigation Into PepGen Inc

Accesswire August 20, 2024

PepGen Appoints Paul Streck, M.D., MBA, as Executive Vice President, Head of Research & Development

Business Wire August 20, 2024

Investors Invited To Lead The Schall Law Firm In The Securities Fraud Investigation Into PepGen Inc

Accesswire August 19, 2024

Shareholders Encouraged To Lead The Schall Law Firm's Securities Fraud Investigation Into PepGen Inc

Accesswire August 18, 2024

Investors Invited To Spearhead The Schall Law Firm's Securities Fraud Investigation Into PepGen Inc

Accesswire August 17, 2024

Shareholders Invited To Join In The Schall Law Firm's Securities Fraud Investigation Into PepGen Inc

Accesswire August 16, 2024

Investors Encouraged To Participate In The Schall Law Firm's Securities Fraud Investigation Into PepGen Inc

Accesswire August 15, 2024